Navigation Links
DaVita Announces Completion of Government Investigation
Date:5/4/2009

EL SEGUNDO, Calif., May 4 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA) announced that the United States Attorney's Office for the Eastern District of New York has informed the company that it has completed its investigation without taking any action against the company. The company was first issued a formal subpoena in October 2004 and fully cooperated with the investigation. No charges were made against the company, no fines were assessed and no mandatory policy changes were required in connection with this investigation.

(Logo http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO )

"We are pleased that the government, after a lengthy and thorough review, has decided to close this broad investigation into our business practices. We are proud of our culture of regulatory compliance at DaVita," said Chairman and CEO Kent Thiry.

DaVita Inc. is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
2. DaVita 1st Quarter 2009 Results
3. DaVita Wins Silver in Web Health Awards
4. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
5. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
6. DaVita Wins Recruiting Department of the Year Award
7. Natalie Cole Lauds DaVita and CEO Kent Thiry on Larry King Live
8. DaVitas Customized Lifestyle Management Programs Assist Employees to Meet Their Lifestyle Goals
9. DaVitas IMPACT Program Reduces Mortality for New Dialysis Patients
10. DaVita Raises Awareness on World Kidney Day
11. FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... institution’s inaugural K-20 Education Summit to be held March 23-25, 2017 in Tampa, ... Jan. 25, 2017. , The keynote speakers include Dr. Michelle R. Weise, executive ...
(Date:1/23/2017)... ... ... Wooden and plastic balance boards have been around since at least the 1950s and are ... the first and only balance board to use a patent-pending design featuring high-pressure inflation technology ... time as well as skill-level adjustable for all ages and abilities. The board can ...
(Date:1/23/2017)... SC (PRWEB) , ... January 23, 2017 , ... ... is the premiere organization in North America for the scientific development, healthcare training ... 2017 Annual Scientific Session, and its 2017 AAT Member Certification Qualification Courses for ...
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture ... choosing the right method is paramount to success. Selecting an inappropriate measurement method ... where multiple persons use the same equipment. Rare or expensive substances are wasted ...
(Date:1/23/2017)... ... January 23, 2017 , ... Old School Labs™, makers ... Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing team of brand ambassadors. ... bodybuilder in 2012 and in less than a year was able to turn professional, ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical collaboration agreement with the Children,s Hospital of ... M.D., a US key opinion leader in the mitochondrial medicine ... ... from NeuroVive,s research program, NVP015, in certain experimental disease models. ...
(Date:1/21/2017)... Research and Markets has announced the addition of ... Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab ... Cancer, HIV/AIDS etc.), Forecast to 2022" report to their ... ... especially clinical lab testing, which has evolved as a major ...
(Date:1/21/2017)... CAMBRIDGE, Mass. , Jan. 20, 2017 ... the Keystone Symposia Conference, "PI3K Pathways in ... Pharmaceuticals, Inc. (NASDAQ: INFI ... oral immuno-oncology development candidate that selectively inhibits ... is able to help overcome resistance to ...
Breaking Medicine Technology: